Coronavirus Notebook: WHO OKs Bharat’s Covaxin, AZ Pulls Swiss Vaxzevria Filing

 
• By Ian Schofield

The US FDA has rejected an emergency use authorization application for NRx Pharmaceuticals’ Zyesami (aviptadil) for use in COVID-19 patients with respiratory failure. The UK has revamped its emergency delivery service for drugs that experience shortages as a result of the pandemic and other factors.

A bottle of vaccine and a syringe on a white table on a blue background
Bharat Biotech's coronavirus vaccine can now be more widely used • Source: Alamy

More from International

More from Geography